spacer
home > epc > autumn 2017 > clear lines
PUBLICATIONS
European Pharmaceutical Contractor

Clear Lines

EPC: What is barcode labelling and how is it currently utilised in pharma?

Laura Johnson: Barcode labelling is central to a range of mission-critical enterprise operations, including production and distribution; supply chain traceability, management and control; and final delivery. Each organisation has its own unique set of business processes and considerations that must be accommodated.

Barcodes are especially important in the pharmaceutical space, where they are currently used to identify the batch or lot for products travelling through the supply chain. In November 2015, the FDA issued final guidance for the Drug Supply Chain Security Act (DSCSA), detailing the use of 2D barcodes for consumer safety.

How does it ensure quality?

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Laura Johnson is a Life Sciences Industry Expert at Loftware with over 20 years of expertise working with both pharma and medical device manufacturers to improve processes and meet regulatory requirements, such as serialisation, UDI and secure supply chain. Her career has also focused on the application of technology to drive efficiencies in manufacturing, warehousing and distribution environments. Laura’s expertise is on leveraging core functionality within major ERP systems, such as SAP and oracle, and implementing automatic data capture technologies, including vision inspection, printing, shop floor devices, barcode and RFID data collection.
spacer
Laura Johnson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Distributor Oppurtunities

Have an appetite for success – Want to expand your product portfolio – Fancy being part of something special??
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

Nordic Life Science Days 10/12 September 2019

10-12 September 2019, Malmo Sweden

Nordic Life Science Days is the largest Nordic partnering conference for the global Life Science industry. Bringing together the best talents in Life Science, offering amazing networking and partnering opportunities, providing inputs and content on the most recent trends. Nordic Life Science Days attracts leading decision makers from the Life Science sector, not only from biotech, pharma and medtech but also from finances, research, policy and regulatory authorities.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement